Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling

2015 ◽  
Vol 470 (1) ◽  
pp. 53-64 ◽  
Author(s):  
Arnold Junior Tatsinkam ◽  
Barbara Mulloy ◽  
Christopher C. Rider

Gremlin, a secreted protein critical in foetal kidney development, is known to bind to the sulfated polysaccharides, heparin and heparan sulfate (HS). In the present study, we employed targeted mutagenesis to map its heparin-binding site. We also demonstrate that gremlin forms non-covalent dimers.

Biochemistry ◽  
1994 ◽  
Vol 33 (24) ◽  
pp. 7731-7735 ◽  
Author(s):  
Stuart R. Stone ◽  
Marianne L. Brown-Luedi ◽  
Giorgio Rovelli ◽  
Angelo Guidolin ◽  
Elaine McGlynn ◽  
...  

FEBS Letters ◽  
2015 ◽  
Vol 589 (24PartB) ◽  
pp. 4026-4032 ◽  
Author(s):  
Kaneyoshi Takahashi ◽  
Arisa Imai ◽  
Masumi Iijima ◽  
Nobuo Yoshimoto ◽  
Andrés D. Maturana ◽  
...  

1996 ◽  
Vol 76 (01) ◽  
pp. 005-008 ◽  
Author(s):  
Jean Claude Lormeau ◽  
Jean Pascal Herault ◽  
Jean Marc Herbert

SummaryWe examined the effect of the synthetic pentasaccharide representing the minimal binding site of heparin to antithrombin on the antithrombin-mediated inactivation of factor Vila bound to tissue factor. This effect was compared to the effect of unfractionated heparin. Using purified recombinant human coagulation factors and either a clotting or an amidolytic assay for the determination of the residual activity of factor Vila, we showed that the pentasaccharide was an efficient antithrombin-dependent inhibitor of the coagulant activity of tissue factor-factor Vila complex. In our experimental conditions, assuming a mean MW of 14,000 for heparin, the molar pseudo-first order rate constants for ATIII-mediated FVIIa inhibition by ATIII-binding heparin and by the synthetic pentasaccharide were found to be similar with respective values of 104,000 ± 10,500 min-1 and 112,000 ± 12,000 min-1 (mean ± s.e.m., n = 3)


1991 ◽  
Vol 266 (12) ◽  
pp. 7812-7818 ◽  
Author(s):  
F J Barkalow ◽  
J E Schwarzbauer

2000 ◽  
Vol 24 (1) ◽  
pp. 43-51 ◽  
Author(s):  
H Song ◽  
J Beattie ◽  
IW Campbell ◽  
GJ Allan

Using site-directed mutagenesis, we have undertaken a study of a potential IGF-binding site in the C-terminal domain of rat IGFBP-5, lying close to or within a previously described heparin-binding domain (residues 201-218) in this protein. After analysis of binding activity using three different methods - ligand blotting, solution phase equilibrium binding and biosensor measurement of real-time on- and off-rates - we report that the mutation of two highly conserved residues within this region (glycine 203 and glutamine 209) reduces the affinity of the binding protein for both IGF-I and IGF-II, while having no effect on heparin binding. In addition, we confirm that mutation of basic residues within the heparin-binding domain (R201L, K202E, K206Q and R214A) results in a protein that has attenuated heparin binding but shows only a small reduction in affinity for IGF-I and -II. Previous findings have described the reduction in affinity of IGFBP-5 for IGFs that occurs after complexation of the binding protein with heparin or other components of the extracellular matrix (ECM) and have postulated that such an interaction may result in conformational changes in protein structure, affecting subsequent IGF interaction. Our data suggesting potential overlap of heparin- and IGF-binding domains argue for a more direct effect of ECM modulation of the affinity of IGFBP-5 for ligand by partial occlusion of the IGF-binding site after interaction with ECM.


Biochemistry ◽  
1999 ◽  
Vol 38 (20) ◽  
pp. 6479-6488 ◽  
Author(s):  
Roland Montserret ◽  
Elisabeth Aubert-Foucher ◽  
Michael J. McLeish ◽  
Joanna M. Hill ◽  
Damien Ficheux ◽  
...  

2000 ◽  
Vol 10 (3) ◽  
pp. 275-278 ◽  
Author(s):  
K. Roman ◽  
E. Rosenthal ◽  
R. Razavi

AbstractWe report a newborn male who presented with severe central cyanosis on the third day of life. Partial thrombotic obstruction of the pulmonary trunk secondary to Antithrombin III (homozygous defect of heparin binding site) deficiency was subsequently diagnosed. Surgical thrombectomy, and infusions of Antithrombin III concentrate, led to a successful outcome. We postulate that intrauterine thrombosis occurred to give this unusual presentation.


Sign in / Sign up

Export Citation Format

Share Document